DNLI
Price
$23.58
Change
+$0.17 (+0.73%)
Updated
Jan 30 closing price
Capitalization
3.37B
31 days until earnings call
PTH
Price
$43.66
Change
+$0.82 (+1.91%)
Updated
Jan 30 closing price
Net Assets
126.28M
Ad is loading...

DNLI vs PTH

Header iconDNLI vs PTH Comparison
Open Charts DNLI vs PTHBanner chart's image
Denali Therapeutics
Price$23.58
Change+$0.17 (+0.73%)
Volume$803.36K
Capitalization3.37B
Invesco Dorsey Wright Healthcare MomtETF
Price$43.66
Change+$0.82 (+1.91%)
Volume$9.29K
Net Assets126.28M
DNLI vs PTH Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. PTH commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Buy and PTH is a Buy.

Ad is loading...
COMPARISON
Comparison
Jan 31, 2025
Stock price -- (DNLI: $23.58)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green while.

  • DNLI’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 5 TA indicator(s) are bullish.

  • DNLI’s TA Score: 5 bullish, 5 bearish.

Price Growth

DNLI (@Biotechnology) experienced а +1.29% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.11%. For the same industry, the average monthly price growth was +1.05%, and the average quarterly price growth was +4.49%.

Reported Earning Dates

DNLI is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-1.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
88
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIPTH
RSI
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
86%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 8 days ago
79%
Bearish Trend 24 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
87%
View a ticker or compare two or three
Ad is loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RDWAX10.800.06
+0.56%
American Funds Dvlpg Wld Gr&Inc R1
FCIGX34.89N/A
N/A
Fidelity Advisor Small Cap Growth I
JFARX38.80N/A
N/A
JHancock Fundamental All Cap Core R4
RMBNX43.86N/A
N/A
RMB Mendon Financial Services C
APLIX11.73N/A
N/A
Cavanal Hill Hedged Income Investor